Quarterly report pursuant to Section 13 or 15(d)

Share-based Compensation

v3.21.2
Share-based Compensation
6 Months Ended
Jun. 30, 2021
Share-based Compensation  
Share-based Compensation

Note 12. Share-based Compensation

The Company’s 2017 Stock Plan (the “Plan”) provides for granting stock options and restricted stock awards to employees, directors, contractors and consultants of the Company. A total of 3,182,335 shares of common stock are authorized to be issued pursuant to the Plan. As of June 30, 2021, there were 2,739,261 shares available for future grants under the Plan.

The Company’s 2019 Omnibus Stock Incentive Plan (the “2019 Plan”) provides for granting stock options and restricted stock awards to employees, directors, agents, contractors and consultants of the Company. A total of 1,060,778 shares of common stock are authorized to be issued pursuant to the 2019 Plan. As of June 30, 2021, there were 455,981 shares available for future grants under the 2019 Plan.

Restricted Stock Awards

    

    

Weighted

Average Grant

Shares

Date Fair Value

Nonvested at December 31, 2020

 

390,787

 

$

13.56

Granted

 

157,267

 

38.65

Vested

 

(42,513)

 

(39.26)

Forfeited

 

(6,735)

 

(11.70)

Nonvested at June 30, 2021

 

498,806

$

19.31

In March 2021, pursuant to the 2019 Plan, the Company granted 82,003 restricted stock awards to certain employees and agents, of which 4,564 awards vested immediately and the remaining 77,439 awards will vest three years from the grant date subject to continuous service with the Company. The fair value of these restricted stock awards was $32.87 per share based on the Company’s closing stock price on the grant date.

In March 2021, pursuant to the 2019 Plan, in connection with the Company’s acquisitions of Naberly and Red Barn (See Note 3), the Company granted 44,568 restricted stock awards to former founders who are now employees of the Company, of which 10,478 will vest one year from the grant date, and the remaining 34,090 will vest 18 months from the grant date. The fair value of the Company’s restricted stock awards granted in March 2021 was $44.00 per share based on the Company’s closing stock price on the grant date.

Stock Option Awards

A summary of stock option activity under the Plans are as follows:

    

    

    

Weighted Average

    

Weighted

Remaining

Options

Average

 Contractual Term

Aggregate

Outstanding

Exercise Price

in Years

intrinsic value

Balance at December 31, 2020

 

47,332

$

8.03

 

8.8

$

1,325,903

Granted

 

13,638

 

44.00

 

 

Exercised

 

(16,972)

 

4.71

 

 

Balance at June 30, 2021

 

43,998

$

20.46

 

8.6

$

695,500

Options exercisable at June 30, 2021

 

20,158

$

4.71

 

7.9

$

566,037

In March 2021, pursuant to the 2019 Plan, the Board granted stock option awards to the independent directors to acquire shares of common stock with an exercise price of $44.00 per share. The stock options will vest on the earlier of (a) one year from the date of grant and (b) the next annual stockholder meeting, subject to the director’s continued service on the Board.

Stock based compensation related to the Company’s stock plans are as follows:

Three months ended

    

Six months ended

June 30,

June 30,

    

2021

    

2020

    

2021

    

2020

General and administrative

$

917,569

$

8,660

$

1,515,458

$

39,274

Commission and other agent-related cost

 

275,885

 

91,833

 

548,071

 

185,940

Total stock-based compensation

$

1,193,454

$

100,493

$

2,063,529

$

225,214